Innovating Works

FUNDACION INSTITUTO DE INVESTIGACION MAR...

Activa
SiCNeutronFlash: Out-of-field neutron dosimetry for FLASH therapy based on SiC sensors FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA participó en un HORIZON EUROPE: HORIZON-MSCA-2022-PF-01 Cancer is a major public health problem worldwide. According to the latest research, 20% of people will develop cancer at some point during...
2023-04-12 - 2025-11-30 | Financiado
halt-RONIN: Discovering chronic inflammation biomarkers that define key stages in the Healthy to NASH non alcoh... FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA participó en un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Non-alcoholic fatty liver disease (NAFLD) is a multifactorial chronic inflammatory disease that is prevalent in 1 of 4 individuals with a si...
2022-11-22 - 2026-11-30 | Financiado
TIMELY: A patient centered early risk prediction prevention and intervention platform to support the conti... FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA participó en un H2020: H2020-SC1-DTH-2018-2020 Coronary artery disease (CAD) remains the leading cause of disease burden globally. CAD develops slowly, usually over decades, and depends o...
2020-12-08 - 2025-03-31 | Financiado
HELICAL: HEalth data LInkage for ClinicAL benefit FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA participó en un H2020: H2020-MSCA-ITN-2018 European researchers have made leading contributions to the large genomic, transcriptomic and clinical datasets from patients with chronic d...
2018-08-31 - 2023-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.